Issa Mohamed Khairie (CIK 2050035) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-20). Recent activity: Sell INCY (1,093 shares), Buy INCY (7,857 shares), Sell INCY (1,099 shares), Sell INCY (8,264 shares), Sell INCY (10,856 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-20 | INCYTE CORP (INCY) | EVP, Head of U.S. Commercial | Sell | 1,093 | $125,706 |
| 2026-07-20 | INCYTE CORP (INCY) | EVP, Head of U.S. Commercial | Buy | 7,857 | $0 |
| 2026-07-16 | INCYTE CORP (INCY) | EVP, Head of U.S. Commercial | Sell | 1,099 | $126,484 |
| 2026-01-08 | INCYTE CORP (INCY) | EVP, Head of US Oncology | Sell | 8,264 | $881,438 |
| 2026-01-08 | INCYTE CORP (INCY) | EVP, Head of US Oncology | Sell | 10,856 | $1.2M |
| 2025-07-17 | INCYTE CORP (INCY) | EVP, Head of US Oncology | Buy | 8,769 | $0 |
| 2025-07-02 | INCYTE CORP (INCY) | EVP, Head of US Oncology | Buy | 27,812 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-20